Sunstone Life Science Ventures is an independent European venture capital investment firm focused on early-stage life science companies developing novel therapeutics for humans. Their primary goal is to transform innovative scientific discoveries into valuable new products that enhance patient outcomes and generate returns for innovators, investors, and healthcare systems. The firm seeks to identify, enable, and empower the most promising therapeutics innovations, contributing to bringing new drugs into the market and supporting numerous clinical trials. They invest across preclinical drug candidates through new drugs approved for market.
Preferred startup development maturity for initial funding deployment.
Therapeutics, Biotechnology, Pharmaceuticals, Life Science
Core thematic spaces, technologies, and target market segments of interest.
Standard financial allocation per investment round.
Direct Verification Contact Email Pattern
Thesis Dossier Analysis Scorecard
Our agent analyzer scanned portfolio holdings and verified absolute match parameters...